ProKidney Corp’s recent filing unveils that its Chief Regulatory Officer Weber Darin J. unloaded Company’s shares for reported $0.31 million on Jul 08 ’25. In the deal valued at $3.02 per share,103,480 shares were sold. As a result of this transaction, Weber Darin J. now holds 0 shares worth roughly $0.0.
Then, DARIN J WEBER bought 103,480 shares, generating $62,761 in total proceeds.
Before that, Control Empresarial de Capital bought 387,393 shares. ProKidney Corp shares valued at $276,366 were divested by the Add’l Rep. Persons-see Ex.99-1 at a price of $0.71 per share. As a result of the transaction, Control Empresarial de Capital now holds 73,842,723 shares, worth roughly $223.01 million.
BofA Securities downgraded its ProKidney Corp [PROK] rating to an Underperform from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in late September with a ‘”a Neutral”‘ rating. Guggenheim began covering PROK with “Buy” recommendation on September 10, 2024.
Price Performance Review of PROK
On Friday, ProKidney Corp [NASDAQ:PROK] saw its stock fall -8.48% to $3.02. Over the last five days, the stock has gained 10.22%. ProKidney Corp shares have risen nearly 74.57% since the year began. Nevertheless, the stocks have risen 78.70% over the past one year.
How much short interest is there in ProKidney Corp?
A steep rise in short interest was recorded in ProKidney Corp stocks on 2025-09-30, growing by 2.32 million shares to a total of 10.71 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 8.38 million shares. There was a rise of 21.7%, which implies that there is a positive sentiment for the stock.
